With uncertainty surrounding the future of government funding, the onus is being placed on the private sector to continue driving new discoveries.
Michael Miller, PhD
Advertisement
Articles by Michael Miller, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
3
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
4
Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq
5